Evogene Ltd. EVGN

0.42 0.00 0.00% as of 25 Sep
Market cap
$6.3M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.25 1.91 7.08 17.96 71.30 127.26 51.99 29.19 26.35 19.76
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(3.22) (2.34) (6.74) (13.33) (8.20) (19.26) (8.40) 12.77 (24.98) (30.54)
P/B ratio
0.72 0.72 1.39 0.86 1.05 2.33 0.65 1.01 1.28 1.48
Price to Tangible BV
433.07 4.03 2.57 1.46 1.38 3.25 0.91 1.01 1.28 1.48
EV/Sales
(1.12) (0.84) 1.57 (3.15) 13.38 80.88 (10.27) (1.99) 5.13 6.28
EV/EBITDA
0.37 0.27 0.00 0.22 0.00 0.00 0.42 0.18 0.00 0.00
EV/Operating CF
0.32 0.24 (0.41) 0.22 (0.50) (4.31) 0.44 0.42 (1.09) (3.52)
EV/FCF
0.32 0.23 (0.40) 0.21 (0.49) (4.17) 0.42 0.42 (1.05) (3.29)
Quick Ratio
4.32 0.99 4.95 6.61 8.25 5.36 8.53 10.22 15.61 17.13
Current Ratio
4.54 1.15 4.96 6.71 8.27 5.36 8.53 10.22 15.61 17.13
Net Debt/EBITDA
1.12 0.90 1.30 1.45 1.88 2.18 2.55 3.03 3.62 4.69
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.13 0.12 0.11 0.03 0.01 0.01 0.01 0.03 0.04 0.06
Operating CF/Net income
1.59 1.20 0.90 0.89 0.89 0.83 0.98 0.73 0.76 0.60
Capex/Depreciation
(0.02) (0.33) (0.29) (0.45) (0.38) (0.25) (0.32) (0.19) (0.28) (0.35)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(63.29%) (75.75%) (75.24%) (54.25%) (46.21%) (39.92%) (32.78%) (34.69%) (26.60%) (20.51%)
ROA
(28.33%) (36.24%) (44.54%) (40.23%) (37.50%) (32.63%) (27.85%) (30.46%) (24.01%) (18.79%)
ROIC
0.00% 0.00% 0.00% 0.00% (202.49%) (179.23%) (99.16%) 0.00% 0.00% 0.00%
Return on Tangible Assets
(65.27%) (350.89%) (79.65%) (76.93%) (53.36%) (52.86%) (39.49%) (38.99%) (28.58%) (21.59%)
Average Days of Receivables
178.28 206.49 215.51 398.78 1,150.73 1,261.36 1,042.65 213.32 111.84 74.34
Research and Development Expense of Revenue
207.47% 224.33% 368.39% 1,241.31% 2,271.51% 1,662.21% 2,097.08% 840.64% 502.43% 250.84%
Selling, General and Administrative Expense of Revenue
149.55% 160.95% 171.61% 621.79% 1,074.30% 511.63% 500.00% 201.14% 112.69% 59.46%
Intangible Assets out of Total Assets
0.00 0.31 0.26 0.25 0.20 0.22 0.24 0.00 0.00 0.00
Share Based Compensation of Revenue
16.97% 22.29% 33.28% 70.81% 280.54% 393.94% 209.56% 99.08% 66.37% 45.00%
Graham Net Nets
0.87 (0.32) 0.30 0.55 0.66 0.28 0.97 0.92 0.72 0.63
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(106.36%) (166.31%) (60.92%) (87.67%) (42.07%) (17.45%) (46.71%) (41.41%) (23.34%) (15.16%)
Free Cash Flow Yield
(156.55%) (190.70%) (55.95%) (82.60%) (38.55%) (15.26%) (47.43%) (16.42%) (18.54%) (9.67%)
Revenue per Share
0.49 0.98 1.23 0.41 0.23 0.37 0.29 0.68 1.32 2.57
Operating CF per Share
(1.71) (3.46) (4.70) (5.75) (6.11) (6.93) (6.86) (5.89) (6.20) (4.60)
Capex per Share
(0.01) (0.11) (0.17) (0.28) (0.21) (0.24) (0.35) (0.15) (0.23) (0.32)
Free Cash Flow per Share
(1.72) (3.57) (4.87) (6.03) (6.32) (7.17) (7.21) (6.03) (6.43) (4.91)
Cash per Share
1.65 2.69 6.77 8.58 13.32 17.13 18.20 21.15 27.95 34.65
Shareholders Equity per Share
1.52 2.60 6.25 8.44 15.69 20.20 23.38 19.53 27.02 34.31
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
1.52 2.60 6.25 8.44 15.69 20.20 23.38 19.53 27.02 34.31
Free Cash Flow
(13.56) (20.32) (22.34) (24.85) (25.56) (20.20) (18.57) (15.53) (16.52) (12.50)
Working Capital
12.19 2.89 27.53 32.13 50.01 42.15 43.28 50.06 68.13 84.27
Capital Expenditures
(0.06) (0.62) (0.76) (1.17) (0.85) (0.68) (0.90) (0.37) (0.59) (0.80)
Net Current Asset Value
7.56 (3.44) 12.05 16.42 44.01 36.79 37.88 47.10 64.57 80.79
EV/EBIT
0.31 0.25 0.00 0.20 0.00 0.00 0.37 0.17 0.00 0.00
Capex to Sales
0.01 0.11 0.13 0.70 0.91 0.66 1.20 0.21 0.17 0.12
Net Profit Margin
(220.22%) (295.59%) (423.39%) (1,590.33%) (2,988.49%) (2,247.50%) (2,405.31%) (1,188.21%) (616.33%) (299.57%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
3.04 1.03 1.06 1.03 1.08 1.32 1.07 0.63 0.45 0.35
Cash ROIC
(57.34%) (71.33%) (40.22%) (37.32%) (22.84%) (20.54%) (18.91%) (17.51%) (14.68%) (10.36%)
Accounts Receivable Turnover
1.53 1.72 2.19 0.70 0.29 0.36 0.47 1.70 2.86 2.60
Accounts Payable Turnover
4.39 1.58 1.20 0.73 0.66 0.62 0.33 1.37 2.33 3.64
Inventory Turnover
4.04 2.51 5.27 2.76 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
56.97 188.33 385.06 416.00 696.21 548.77 1,093.91 255.15 142.41 86.09
Days of Inventory on Hand
18.72 278.96 16.39 227.27 43.78 0.00 0.00 0.00 0.00 0.00
Average Receivables
2.52 3.24 2.58 2.38 3.26 2.87 1.59 1.03 1.18 2.52
Average Payables
0.93 1.51 1.41 1.25 1.16 0.93 1.01 1.06 1.22 1.55
Average Inventory
1.01 0.95 0.32 0.33 — — — — — —
Average Assets
29.96 45.48 53.61 66.22 74.11 71.64 65.03 68.15 86.79 104.29
Average Common Equity
13.41 21.76 31.74 49.11 60.15 58.55 55.26 59.84 78.33 95.52

Fold the line items

Columns are period end dates